Lung Cancer Clinical Trial
Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors
Summary
In this study, the researchers investigate the feasibility of using rapid cine MR imaging to provide both offline and online soft-tissue-based image guidance. Such images will provide a significantly more complete picture of the spatial and temporal changes in thoracic anatomy. This more complete information will lay the groundwork for better radiotherapy planning and dose delivery in the presence of respiratory motion.
Full Description
Rapid MRI scans from Stage I-IV non-small-cell lung cancer (NSCLC) patients will be acquired. MR acquisition will be performed without extrinsically administered contrast, using a balanced turbo field echo (TFE) sequence and commercially available coils.
Eligibility Criteria
Inclusion Criteria:
AJCC Stage I, II, III or IV non-small-cell lung cancer to be treated using radiotherapy will be eligible for this study.
Any types and amounts of prior therapy will be allowed for this study.
Subjects must be greater than or equal to 18 years of age. There are no gender or ethnic restrictions.
Ability to understand and the willingness to sign a written informed consent document.
Able to tolerate supine position
ECOG performance status of 3 or less
Exclusion Criteria:
MRI-incompatible metallic implants, embedded metallic objects, implanted biomedical devices e.g., cardiac pacemakers
Women who are pregnant or trying to get pregnant
Pain in supine position
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Dallas Texas, 75390, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.